Is Nature's Sunshine Products, Inc. (NATR) Overvalued?
We dive into why Nature's Sunshine Products, Inc. (NATR) could be considered overvalued on 2026-08-18, based on AAII’s Value Score and Grade.Jenna Brashear
Stock Evaluator: Nature's Sunshine Products, Inc. (NATR)
Nature's Sunshine Products, Inc. NATR
$13.55
-0.06
-0.44%
September 11, 2026 4:00:00 PM
EST
Volume: 122,820
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Consumer Staples | Personal Care Products |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system. It also offers cardiovascular products; digestive products to regulate intestinal and digestive functions; personal care products for external use, including oils and lotions, aloe vera gel, herbal shampoo, herbal skin treatment, toothpaste, and skin cleanser. In addition, the company provides weight management products, such as meal replacements and products that increase caloric burn rate. It offers its products under the Nature’s Sunshine and Synergy Worldwide brands through its network of independent consultants to customers. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.
Commentary & Analysis
Why Nature's Sunshine Products, Inc.’s (NATR) Stock Is Down 17.11%
As of Friday, August 07, Nature's Sunshine Products, Inc.’s NATR share price has dipped by 17.11%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Nature's Sunshine Products, Inc.’s (NATR) Stock Is Down 17.99%
As of Friday, August 07, Nature's Sunshine Products, Inc.’s NATR share price has dipped by 17.99%, which has investors questioning if this is right time to buy.Omar Beirat
3 Undervalued Personal Care Products Stocks for Wednesday, July 29
Discover the top 3 undervalued Personal Care Products stocks for Wednesday, July 29 based on AAII’s Stock Grades.Rosalio Madrigal
3 Undervalued Personal Care Products Stocks for Monday, June 29
Discover the top 3 undervalued Personal Care Products stocks for Monday, June 29 based on AAII’s Stock Grades.Michael Rose
Financial Summary
| Share Statistics | NATR | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $238.4 | $263.1 | 29% |
|
| Shares Out (Mil) | 18.3 | 32.8 | 29% |
|
| Institutional Ownership | 95.3% | 58.4% | 67% |
|
| Float (Mil) | 12.5 | 37.3 | 22% |
|
| Beta | 0.89 | 0.54 | 53% |
|
| Avg Daily Volume (000s) | 167 | 105 | 43% |
|
| Price Change (52-week) |
(21.0%) | 57.2% | 31% |
|
| Growth | NATR | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 4.5% | 0.9% | 34% |
|
| Net Income (5yr) | (1.8%) | (7.5%) | 37% |
|
| EPS (5yr) | (0.2%) | (0.2%) | 31 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (23.7%) | (14.9%) | 27% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | $0.265 | $1.080 | $1.230 | |
| Month Ago EPS | $0.265 | $1.080 | $1.230 | |
| # Rev Up | 1 | 0 | 1 | |
| # Rev Down | 0 | 1 | 0 | |
| Three Months Ago EPS | $0.330 | $1.205 | $1.355 | |
| Year/Year Chg | 39.5% | 1.9% | 15.1% | |
| Financials | NATR | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $492 | $571 | 41% |
|
| Net Income (TTM) (Mil) | $18 | ($1) | 48% |
|
| EPS (TTM) | $1.027 | $0.000 | 61% |
|
| Operating Cash Flow (TTM) (Mil) | $27 | $25 | 43% |
|
| Net Cash Flow (TTM) (Mil) | $1 | $1 | 46% |
|
| Long-Term Debt (Q1) (Mil) | $17 | $42 | 32% |
|
| Enterprise Value (Q1) (Mil) | $227 | $346 | 27% |
|
| Valuation | NATR | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.41 | 1.83 | 36% |
|
| P/E | 13.6 | 15.3 | 33% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 0.6 | na |
|
| Ratios | NATR | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 73.2% | 62.9% | 83% |
|
| Net Margin | 3.7% | 1.2% | 44% |
|
| ROA | 7.0% | (1.5%) | 79% |
|
| ROE | 11.1% | 4.8% | 60% |
|
| Liabilities to Assets | 34.8% | 49.5% | 26% |
|
| F-Score | 8 | 4 | 93% |
|
Passing Stock Screens
As of 9/11/2026, from a list of 60 stock screening strategies,
FACTOR STRATEGY
Price-to-Sales Screen
Factors: Value, Growth
Research indicates that using price-to-sales ratios may lead to better investment results than price-to-book-value ratios or price-earnings ratios.
| Performance Since Inception: | 13.2% |
| +/- S&P 500: | +5.7 |
